Drug factory · FDA FEI 3002806667
CHEMI SpA
VIA VADISI 5, Patrica, Italy
Problems found, fixed voluntarily at FDA's last inspection, Jan 26, 2024.
Voluntary Action Indicated: inspectors found problems, but not serious enough for FDA to take action. The company is expected to fix them.
6 drug inspections on record since 2010: 0 with no problems, 6 with problems fixed voluntarily, 0 with FDA action.
What it does, for whom
| Drug | Role | For | NDC |
|---|---|---|---|
| Givinostat | Makes the active ingredient and tests it | Italfarmaco S.p.A | 11797-110 |
FDA inspection history
| Ended | Result | Program | Problems noted |
|---|---|---|---|
| Jan 26, 2024 | Problems found, fixed voluntarily | Drug Quality Assurance | — |
| Sep 20, 2019 | Problems found, fixed voluntarily | Drug Quality Assurance | — |
| Oct 12, 2017 | Problems found, fixed voluntarily | Drug Quality Assurance | — |
| May 12, 2016 | Problems found, fixed voluntarily | Drug Quality Assurance | — |
| Mar 28, 2014 | Problems found, fixed voluntarily | Drug Quality Assurance | — |
| Sep 24, 2010 | Problems found, fixed voluntarily | Drug Quality Assurance | — |
Registered with FDA for: analysis; api manufacture.